ClinicalTrials.gg
CompletedNCT06276595TODOSUpdated Jul 30, 2025

Telling Our Daughters Our Story

An interventional study of Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS) and Control condition - 3 Monthly Group Activities in the Community in Substance Use and Sexual Behavior, sponsored by Johns Hopkins Bloomberg School of Public Health. Completed at 1 site in United States. Open to female participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2025-07-30.

Sponsored by Johns Hopkins Bloomberg School of Public Health · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 4 years 10 months after the study started (first participant enrolled Mar 2019, registered Feb 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
183
Allocation
Randomized
Ages
8 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 19 studies in Substance-Related Disorders by Johns Hopkins Bloomberg School of Public Health — 6 open to participants now, 6 under way, none of them phase 3. Substance-Related Disorders · Johns Hopkins Bloomberg School of Public Health.

Enrollment
11th of 19
183 · median 188
Started
2019
with 1 other
No phase
18 of 19
5 open now
Registered
12th of 19
by date

Among the 19 studies in Substance-Related Disorders by Johns Hopkins Bloomberg School of Public Health, this one is the 11th largest by enrollment, is one of 2 that started in 2019, is one of 18 with no phase, and was the 12th registered.

By phase

19 studies; the count open now beside each. This study's row is marked.

No phasethis study18 · 5 open
Phase 21 · 1 open

By the year they started

First in 2006; this study’s year is marked. 2 started in 2019.

Size and results

Median enrollment 188 across the 19 interventional studies. Of the 13 that completed or were terminated, 2 (15%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 19 studies in Substance-Related Disorders by Johns Hopkins Bloomberg School of Public Health, or all of them as a file.
02

Study summary

The objective of this research study is to evaluate a culturally grounded program among American Indian (AI) female children and the children's female caregivers. This project will evaluate the impact of "Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (henceforth referred to as TODOS) on associated risk and protective factors for early substance use and sexual debut through a randomized controlled trial on the White Mountain Apache (WMA) reservation. The investigators will examine whether the TODOS program effectively reduces risk factors and improves protective factors associated with early substance use and sexual debut, with long term goals of reducing teen pregnancy and teen substance use.

Read the detailed description

The investigators will employ a randomized controlled trial (RCT) design to assess the preliminary impact of the TODOS program on many factors, including improving cultural knowledge, family engagement in Apache culture, mother daughter communication, self-esteem, self-efficacy, social support, attitudes about risky behaviors, and knowledge of reproductive health and substance use. Participants will be caregivers of girls ages 8-11 years.

The TODOS program consists of 11 weekly sessions conducted with girls ages 8-11 and the girl's female caregivers. Five of the 11 sessions will be taught to small groups of girls and the girl's mothers, and 6 of the sessions will be taught to individual girl/female caregivers' dyads. The choice to use a mix of group- and home-based sessions is based on findings from the formative phase about preference that certain topics be taught in groups, and certain topics be taught in individual dyads. Each of the sessions (group and individual) will be 60-90 minutes in duration and delivered by a trained Family Health Coach (FHC).

The investigators will enroll up to 94 dyads into four cohorts, each consisting of 18-26 dyads. Dyads will receive either the TODOS program or a control condition. The control condition will consist of 3 group sessions delivered monthly for three months. The investigators will evaluate the TODOS program's feasibility through process data including attendance forms and session summary feedback forms completed by the FHCs. The investigators will assess program acceptability immediately after program completion through implementation assessments completed by caregiver and children participants. The investigators will assess the program's impact on key outcomes immediately after program implementation, 6-month and 12-month post program implementation.

03

Conditions studied

  • Substance Use
  • Sexual Behavior
04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for Caregivers:

  • Female > 18 years of age
  • Self-identify as Apache
  • Be a caregiver of a girl 8-11 years old who is available to enroll in the study
  • Living within 50 miles of the Whiteriver or Fort Apache, Arizona Johns Hopkins program offices
  • Willing to complete all implementation and follow-up assessments
  • Willing to be randomized
  • Speaks and reads English

Inclusion Criteria for Child Participants:

  • Female, 8-11 years old
  • Have a caregiver enrolled in the study
  • Living within 50 miles of the Whiteriver or Fort Apache, Arizona Johns Hopkins program offices
  • Willing to be randomized
  • Willing to complete all implementation and follow-up assessments
  • Speaks and reads English
  • Not cognitively or visually impaired (able to complete questionnaires)

Exclusion Criteria:

  • Inability to participate in full intervention or evaluation (e.g., planned move, residential treatment, cognitive impairment, etc.)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
183 participants (actual)

Study arms

  • Experimental
    TODOS Intervention

    Participants in the TODOS Intervention Group will receive the intervention "Nowhi Isdza bit Nadagoldi": Telling Our Daughters Our Story. They will receive 11 intervention sessions of 60-90 minutes over 11 weeks.

    Behavioral: Nowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS)

  • Other
    Control condition - 3 Monthly Group Activities in the Community

    Children and their female caregivers randomized to the control group will receive 3 group sessions delivered monthly for three months. The first group session will occur at a community center and will consist of a meal and ice breaker activities. The second group session will consist of going to a movie at the local movie theatre. The third group session will consist of going bowling at the local bowling alley.

    Behavioral: Control condition - 3 Monthly Group Activities in the Community

Interventions

  • BehavioralNowhi Isdza bit Nadagoldi: Telling Our Daughters Our Story (TODOS)

    The TODOS program consists of 11 weekly sessions conducted with girls ages 8-11 and their female caregivers. Five of the 11 sessions will be taught to small groups, and 6 of the Each of the sessions (group and individual) will be 60-90 minutes in duration and delivered by a trained Family Health Coach (FHC). Group sessions will take place at a local community center in a private room.

  • BehavioralControl condition - 3 Monthly Group Activities in the Community

    The control condition consists of 3 group sessions delivered monthly for three months. The first group session will occur at a community center and will consist of a meal and ice breaker activities. The second group session will consist of going to a movie at the local movie theatre The third group session will consist of going bowling at the local bowling alley.

06

What researchers measure

Primary outcomes

  1. Change in child cultural knowledge score on knowledge assessment

    Using a questionnaire developed by the study team, investigators will measure change in knowledge from baseline to immediately following the intervention and 6 months and 12 months after program completion via a knowledge assessment completed by the child. This is a 4- question assessment that is on a 5-point Likert scale (score: 0-20) A higher score indicates higher (greater) knowledge.

    Time frame: Baseline, 11 weeks, 6 months, 12 months

  2. Change in average score on risky behaviors assessment

    Using a questionnaire developed by the study team, the investigators will assess the impact of the TODOS program on child attitudes related to risky behaviors via a 6-item assessment on a 5-point Likert scale (score: 0-30). Investigators will measure change in knowledge from baseline to immediately following the intervention and 6 months and 12 months after program completion via a knowledge assessment completed by the child. A higher score indicates better attitudes (less endorsement of) risk behaviors.

    Time frame: Baseline, 11 weeks, 6 months, 12 months

  3. Change in child reproductive health knowledge via a reproductive health knowledge questionnaire

    Using a questionnaire developed by the study team, investigators will measure change in knowledge from baseline to immediately following the intervention and 6 months and 12 months after program completion via a 3-question knowledge assessment completed by the child (score 0-100). A higher score indicates more knowledge.

    Time frame: Baseline, 11 weeks, 6 months, 12 months

07

Study locations

1 site
  • White Mountain Apache Center for Indigenous Health
    Whiteriver, Arizona 85941, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2019 to primary completion in Mar 2022, 35 months.

Of 814 non-industry interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 53. This study's 35 months is close to that.

Counting every sponsor, half of 854 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 16, 2024
First posted
Feb 26, 2024
StartActual
Mar 30, 2019
Primary completionActual
Mar 22, 2022
CompletionActual
Jul 30, 2024
Last update
Jul 30, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06276595
Collaborators
White Mountain Apache Tribe, Native American Research Center for Health
Responsible party
Sponsor
First posted
Feb 26, 2024
Start date
Mar 30, 2019
Primary completion
Mar 22, 2022
Completion
Jul 30, 2024
Last update
Jul 30, 2025

Study contacts

Mary Barlow, PhD
principal investigator · Johns Hopkins Bloomberg School of Public Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion